Calcium/calmodulin-dependent protein kinase II immunostaining is preserved in Alzheimer's disease hippocampal neurons

Alterations in protein phosphorylation may be important in the pathogenesis of Alzheimer's disease and recent observations suggest that a subset of protein kinase pathways may be selectively altered. Calcium/calmodulin-dependent protein kinase II CaM kinase II) is the most abundant protein kinase in the brain and is believed to play an important role in the regulation of synaptic transmission, long-term potentiation and other forms of neuronal plasticity. We have now evaluated brains of individuals with Alzheimer's disease for changes in the distribution and density of immunoreactivity for the alpha subunit of CaM kinase II. CaM kinase II immunoreactivity was found in cytoarchitectural areas and neurons vulnerable to the formation of neurofibrillary angles and senile plaques. Over 80% of neurons bearing neurofibrillary tangles expressed CaM kinase II. Loss of CaM kinase II immunoreactivity was found in CA1, commensurate with neuronal loss in this area. Remaining CA1 neurons, however, had preserved CaM kinase II immunoreactivity. Preservation in the distribution and density of CaM kinase II immunoreactivity was observed in other hippocampal regions and in a multimodal association area, area 20. These results suggest CaM kinase II expression in the Alzheimer's disease brain is unaltered despite marked neuropathological changes.

[1]  H. Schulman,et al.  Neuronal Ca2+/calmodulin-dependent protein kinases. , 1992, Annual review of biochemistry.

[2]  J. Trojanowski,et al.  Alzheimer disease tangles share immunological similarities with multiphosphorylation repeats in the two large neurofilament proteins. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[3]  E. Masliah,et al.  Protein kinase C alteration is an early biochemical marker in Alzheimer's disease , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  T. Soderling,et al.  Phosphorylation and regulation of glutamate receptors by calcium/calmodulin-dependent protein kinase II , 1993, Nature.

[5]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[6]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[7]  H. J. G. GUNDERSEN,et al.  Some new, simple and efficient stereological methods and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[8]  V. Lee,et al.  Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[9]  R. E. Blair,et al.  Cerebral ischemia decreases endogenous calcium-dependent protein phosphorylation in gerbil brain , 1988, Brain Research.

[10]  Fabio Benfenati,et al.  Synaptic vesicle-associated Ca2+/calmodulin-dependent protein kinase II is a binding protein for synapsin I , 1992, Nature.

[11]  M. Waxham,et al.  In situ hybridization histochemistry of Ca2+/calmodulin-dependent protein kinase in developing rat brain , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  M K Smith,et al.  Calcium/calmodulin-dependent protein kinase II. , 1989, The Biochemical journal.

[13]  C. Gall,et al.  Differential effects of monocular deprivation on glutamic acid decarboxylase and type II calcium-calmodulin-dependent protein kinase gene expression in the adult monkey visual cortex [published erratum appears in J Neurosci 1991 May;11(5):following Table of Contents] , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  P Greengard,et al.  Active catalytic fragment of Ca2+/calmodulin-dependent protein kinase II. Purification, characterization, and structural analysis. , 1991, The Journal of biological chemistry.

[15]  M. Kennedy,et al.  Hippocampal Neurons Predisposed to Neurofibrillary Tangle Formation Are Enriched in Type II Calcium/Calmodulin-Dependent Protein Kinase , 1990, Journal of neuropathology and experimental neurology.

[16]  P. Greengard,et al.  Immunocytochemical localization of calcium/calmodulin-dependent protein kinase II in rat brain. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Sternberger,et al.  Aberrant neurofilament phosphorylation in Alzheimer disease. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Cotman,et al.  Plasticity of hippocampal circuitry in Alzheimer's disease. , 1985, Science.

[19]  B T Hyman,et al.  Functional Alterations in Alzheimer's Disease: Diminution of Cytochrome Oxidase in the Hippocampal Formation , 1993, Journal of neuropathology and experimental neurology.

[20]  John A. Martin,et al.  Localization of the mitogen activated protein kinase ERK2 in Alzheimer's disease neurofibrillary tangles and senile plaque neurites , 1993, Brain Research.

[21]  P. Greengard,et al.  Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Ca2+/calmodulin-dependent protein kinase II. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Hyman,et al.  Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesions , 1992, Neurobiology of Aging.

[23]  P. Vermersch,et al.  Hétérogénéité de la maladie d'Alzheimer , 1993 .

[24]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[25]  B. Hyman,et al.  Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease. , 1994, The American journal of pathology.

[26]  H. Schulman Serine/threonine kinases in the nervous system , 1991, Current Opinion in Neurobiology.

[27]  J. Povlishock,et al.  Global Forebrain Ischemia Results in Decreased Immunoreactivity of Calcium/Calmodulin-Dependent Protein Kinase II , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  F Benfenati,et al.  Synaptic vesicle phosphoproteins and regulation of synaptic function. , 1993, Science.

[29]  Alcino J. Silva,et al.  Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. , 1992, Science.

[30]  M. Kennedy,et al.  Immunoreactivity for a calmodulin-dependent protein kinase is selectively increased in macaque striate cortex after monocular deprivation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Higgins,et al.  In situ hybridization of calcium/calmodulin dependent protein kinase II and tau mRNAs; species differences and relative preservation in Alzheimer's disease. , 1992, Brain research. Molecular brain research.

[32]  E. Masliah,et al.  Protein kinases and phosphorylation in neurologic disorders and cell death. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[33]  E. Masliah,et al.  Differential involvement of protein kinase C isozymes in Alzheimer's disease , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  W. Meier-Ruge,et al.  Neurochemical enzyme changes in Alzheimer's and Pick's disease. , 1984, Archives of gerontology and geriatrics.

[35]  E. Masliah,et al.  Altered Protein Tyrosine Phosphorylation in Alzheimer's Disease , 1991, Journal of neurochemistry.

[36]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[37]  M. Kennedy,et al.  Distinct forebrain and cerebellar isozymes of type II Ca2+/calmodulin-dependent protein kinase associate differently with the postsynaptic density fraction. , 1985, The Journal of biological chemistry.

[38]  E. Masliah,et al.  Aberrant casein kinase II in Alzheimer's disease , 1990, Brain Research.

[39]  J. Baudier,et al.  Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. , 1987, The Journal of biological chemistry.

[40]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[41]  M. Kindy,et al.  Calcium/calmodulin dependent protein kinase II mRNA in the gerbil brain after cerebral ischemia , 1992, Neuroscience Letters.

[42]  J. Bronstein,et al.  Kindling induced changes in calmodulin kinase II immunoreactivity , 1990, Brain Research.